Quote:
Originally Posted by Chris
The AstraZeneca vaccine makes up the bulk of our supply at present. Stories of its effectiveness are obviously of greater interest.
A study of 20 patients has no statistical significance whatsoever - you have consistently felt entitled to question the effectiveness of the AstraZeneca vaccine on a far larger sample of over-65s.
I think you need to decide what you believe and stick to it ...
|
I acknowledge it’s a tiny study and real world results could vary - I’m not sure what’s wrong about that? It obviously needs more research, and indeed as the Pfizer vaccine rolls out in the real world further data can and will emerge.
I hope the emerging data on over 65s for the AstraZeneca vaccine is good, and I’ve acknowledged the scope for other countries to use the doubts as a way to push past the “hardest to reach” and get more vaccine out there from larger sites. I’m not sure what’s wrong about that but I find it hard to believe all these scientists in all these other countries are questioning the data simply to irk the UK as the Daily Express keep telling me.